Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 74-80
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.74
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.74
Table 1 Distribution of age and gender by intervention arm n = 31
| Variable | Itopride | Placebo | P value |
| Age mean (SD) | 34.2 (6.4) | 31.9 (8.5) | 0.40 |
| Gender n (%) | |||
| Male | 10 (66.7) | 11 (68.8) | 1.001 |
| Female | 5 (33.3) | 5 (31.3) | |
| Hb (g/dL) mean (SD) | 13.6 (2.3) | 14.1 (1.7) | 0.50 |
| WBC (× 10 Eq/L) mean (SD) | 8.1 (2.0) | 7.7 (1.9) | 0.52 |
| Platelet count (× 10 Eq/L) mean (SD) | 257.3 (59.5) | 250.5 (57.2) | 0.75 |
| Creatinine (mg/mL) median (IQR) | 0.9 (0.5) | 0.8 (0.3) | 0.05 |
| SGPT (IU/L) median (IQR) | 20 (9.0) | 25.5 (17.0) | 0.09 |
| Prolactin level (mg/mL) (IQR) | 7.3 (3.6) | 5.7 (2.7) | 0.29 |
| QT interval mean (SD) | 394.1 (21.6) | 399.2 (22.9) | 0.53 |
- Citation: Abid S, Jafri W, Zaman MU, Bilal R, Awan S, Abbas A. Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia. World J Gastrointest Pharmacol Ther 2017; 8(1): 74-80
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/74.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.74